4) (n = 47) Right grip strength (kg) 22.1 (6.0) (n = 44) 21.7 (4.1) (n = 51) 21.6 (5.8) (n = 48) Leg strength (kg) 28.2 (7.8) 30.1 (6.7) 29.7 (8.2) PASE Physical Activity Scale for the Elderly Exercise class attendance Exercise class attendance for participants who were imaged using pQCT

imaging for BT was 65 %; RT1 was 71 %, and RT2 was 70 %. Adverse events click here For the full RCT (n = 155), 23 women reported adverse musculoskeletal events over the 1-year intervention. There were significant between-group differences (P = 0.02) with 5 women from RT2 (n = 46, 11 %), 4 women from BT (n = 42, 10 %), and 14 women from RT1 (n = 47, 30 %) reporting an event. One participant from the BT group had an in-class fall, but no injury was reported. All documented adverse events were resolved within 4 weeks. Functional status Compared with the BT group, the mean difference in change for 6MWT

for the RT1 group from baseline to 6 STAT inhibitor months was 1.6 m (P = 0.87) and 11.6 m at 12 months (P = 0.40); and for the RT2 group, at 6 months, it was 9.8 m (P = 0.34) and 25.0 m (P = 0.08) at 12 months. Tibial CovBMD The data are summarized in Table 2, and values at baseline and 6 and 12 months are shown in Fig. 2. After adjusting for baseline tibial CovBMD, there was no statistically significant difference at 12 months between BT and both phosphatase inhibitor library RT groups, but there was a statistically significant difference between BT and RT2 groups in CovBMD at 6 months. Importantly, all groups maintained tibial CovBMD over 12 months; the estimated mean absolute changes were small (−2.6 (BT), −1.8 (RT1), −4.7 (RT2) C1GALT1 mg/cm3) representing decreases from the mean baseline score

of less than −0.5 %. Table 2 Baseline values with adjusted absolute and percent mean change from baseline by group for tibial cortical volumetric bone density (CovBMD), total area (ToA), and bone strength (I max) at the midtibia (50 % site) in older women   Baseline, mean (SD) 6-Month absolute mean change (percent mean change) 12-Month absolute mean change (percent mean change) BT RT1 RT2 BT RT1 RT2 BT RT1 RT2 CovBMD (mg/cm3) 1,077.41 (43.1) 1,087.76 (42.0) 1,058.67 (60.4) 2.3 (0.21) 0.84 (0.08) −4.79 (−0.45) −2.57 (−0.24) −1.81 (−0.17) −4.67 (−0.45) ToA (mm2) 418.12 (51.3) 416.5 (57.72) 426.60 (45.65) −0.63 (−0.15) 0.61 (0.15) 1.52 (0.36) 1.42 (0.34) 0.86 (0.21) 0.93 (0.22) I max (mm4) 19,404.4 (4,515.1) 19,429.93 (5,201.0) 20,169.89 (4,858.2) −83.26 (−0.43) 69.54 (0.36) 40.82 (0.20) 101.51 (0.52) 124.83 (0.64) 9.94 (0.05) CovBMD volumetric cortical bone mineral density, I max bone strength, ToA total area, BT balance and tone, RT1 resistance training once per week, RT2 resistance training twice per week Fig.